Auteur L. WIESSING
|
Documents disponibles écrits par cet auteur (46)
Ajouter le résultat à votre sélection Affiner la recherche
L. WIESSING ; G. LIKATAVICIUS ; D. KLEMPOVA ; D. HEDRICH ; NARDONE A. ; P. GRIFFITHS | 2009
PériodiqueENGLISH : HIV-prevention measures specific to injection drug users (IDUs), such as opioid substitution treatment and needle-and-syringe programs, are not provided in many countries where injection drug use is endemic. We describe the incidence[...]ENGLISH : Aims. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and pro[...]NouveautéB. HUGHES ; L. WIESSING ; D. DES JARLAIS ; P. GRIFFITHS | 2018
Dans International Journal of Drug Policy (Vol.51, January 2018) Article : PériodiqueCannabis policies are changing in some countries. This may have consequences that extend beyond cannabis-specific outcomes, such as an impact on the consumption patterns of other substances. Changes in cannabis policies may also influence policy[...]EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | 2015
Document texte diversDrug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]V. A. GYARMATHY ; I. GIRAUDON ; D. HEDRICH ; L. MONTANARI ; B. GUARITA ; L. WIESSING | 2009
Dans Eurosurveillance (Vol.14, n°9, 05 March 2009) Article : PériodiqueProblem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess publ[...]G. HAY ; N. McKEGANEY ; E. BIRKS ; L. WIESSING ; R. HARTNOLL ; P. Y. BELLO ; C. M. COMISKEY ; D. D'IPPOLITI ; A. DOMINGO-SALVANY ; FREIRE S. ; M. MOREIRA ; NORÉN A. ; PARTANEN P. ; POLITIKOU K. ; SEIDLER D. ; F. SMIT ; TOET J. ; A. UHL ; VIRTANEN A. | 1997
RapportENGLISH : This report presents the findings from an EMCDDA funded Methodological Pilot Study of Local Level Prevalence Estimates. Following on from a joint EMCDDA / Pompidou Group meeting, comparative pilot studies to improve the prevalence es[...]L. WIESSING ; R. HARTNOLL ; C. ROSSI | 2002
Dans Bulletin des Stupéfiants (Vol.53, n°1-2, 2001) Article : PériodiqueFRANÇAIS: Les indicateurs et les modèles peuvent aider à étudier et à comprendre l'épidémiologie de l'usage de drogues au niveau international ou global. Les indicateurs d'usage de drogues sont généralement fondés sur les données normalement di[...]C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN | 2006
PériodiqueENGLISH : OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature r[...]F. SMIT ; TOET J. ; H. VAN OERS ; L. WIESSING | 2003
Dans Addiction Research and Theory (Vol.11, n°6, December 2003) Article : PériodiqueENGLISH : Objective : To assess the applicability and validity of the Multiple Indicator Method for combining sparsely available local prevalence estimates of problem drug use into a national estimate. Method : Local estimates of problem drug [...]L. KRAUS ; R. AUGUSTIN ; M. FRISCHER ; P. KÜMMLER ; A. UHL ; L. WIESSING | 2003
Dans Addiction (Vol.98, n°4, April 2003) Article : PériodiqueFRANÇAIS : A partir des données des services de traitement et de la police, des données sur la mortalité et le VIH/sida, la prévalence des problèmes liés à l'usage de drogues a été estimée dans les pays de l'Union Européenne et en Norvège. Six[...]ENGLISH : Aims: Throughout the European Union efforts are made to obtain national estimates of problem drug use. These estimates are required for policy making. Given the importance of the estimates, much depends on their validity. Here we use[...]M. HICKMAN ; C. TAYLOR ; A. CHATTERJEE ; L. DEGENHARDT ; M. FRISCHER ; G. HAY ; K. TILLING ; L. WIESSING ; P. GRIFFITHS ; R. McKETIN | 2002
PériodiqueLes décideurs ont de plus en plus besoin d'estimations de la prévalence de la consommation problématique de drogues, comme l'usage par voie intraveineuse et la consommation de "crack". Dans cet article, les auteurs passent en revue les méthodes [...]L. WIESSING ; B. GUARITA ; I. GIRAUDON ; BRUMMER-KORVENKONTIO H. ; M. SALMINEN ; COWAN S. A. | 2008
Dans Eurosurveillance (Vol.13, n°21, 22 May 2008) Article : PériodiqueENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008
PériodiqueENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Monitoring the incidence of problem drug use - the rate at which people who will become problem users start using or injecting drugs for the first time - plays an important part in tracing new trends in Europe’s drug situation and in helping to [...]